An agomir of miR-144-3p accelerates plaque formation through impairing reverse cholesterol transport and promoting pro-inflammatory cytokine production

PLoS ONE

Volumn 9, Issue 4, 2014, Pages

  Hu, Yan Wei ^a   Hu, Ya Rong ^a   Zhao, Jia Yi ^a   Li, Shu Fen ^a   Ma, Xin ^a   Wu, Shao Guo ^a   Lu, Jing Bo ^a   Qiu, Yu Rong ^a   Sha, Yan Hua ^a   Wang, Yan Chao ^a   Gao, Ji Juan ^a   Zheng, Lei ^a   Wang, Qian ^a  

^a SOUTHERN MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ABC TRANSPORTER A1; APOLIPOPROTEIN E; ASPARTATE AMINOTRANSFERASE; CREATINE KINASE; CREATINE KINASE MB; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INTERLEUKIN 1BETA; LACTATE DEHYDROGENASE; MICRORNA; MICRORNA 144 3P; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; ABCA1 PROTEIN, HUMAN; AUTACOID; CHOLESTEROL; CYTOKINE; LIPOPROTEIN; MIRN144 MICRORNA, HUMAN; MIRN144 MICRORNA, MOUSE;

ACUTE HEART INFARCTION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ATHEROGENESIS; ATHEROSCLEROTIC PLAQUE; CHOLESTEROL BLOOD LEVEL; CHOLESTEROL TRANSPORT; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE COURSE; DOWN REGULATION; FOAM CELL; GENE EXPRESSION REGULATION; GENE TARGETING; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MACROPHAGE; MALE; MOUSE; NONHUMAN; ADULT; AGONISTS; ANIMAL; BIOSYNTHESIS; BLOOD; C57BL MOUSE; CELL LINE; DEFICIENCY; FEMALE; GENETICS; HEART INFARCTION; HOMEOSTASIS; INFLAMMATION; LIPID METABOLISM; LIVER; METABOLISM; MIDDLE AGED; PATHOLOGY; TRANSPORT AT THE CELLULAR LEVEL;

ADULT; ANIMALS; APOLIPOPROTEINS E; ATP BINDING CASSETTE TRANSPORTER 1; BIOLOGICAL TRANSPORT; CELL LINE; CHOLESTEROL; CYTOKINES; FEMALE; HOMEOSTASIS; HUMANS; INFLAMMATION; INFLAMMATION MEDIATORS; LIPID METABOLISM; LIPOPROTEINS; LIVER; MACROPHAGES; MALE; MICE, INBRED C57BL; MICRORNAS; MIDDLE AGED; MYOCARDIAL INFARCTION; PLAQUE, ATHEROSCLEROTIC;

EID: 84899655738     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0094997     Document Type: Article

References (48)

1. Fisher EA, Feig JE, Hewing B, Hazen SL, Smith JD (2012) High-density lipoprotein function, dysfunction, and reverse cholesterol transport. Arterioscler Thromb Vasc Biol 32: 2813-2820.
2. Mahdy Ali K, Wonnerth A, Huber K, Wojta J (2012) Cardiovascular disease risk reduction by raising HDL cholesterol-current therapies and future opportunities. Br J Pharmacol 167: 1177-1194.
3. Hansson GK (2009) Atherosclerosis-an immune disease: The Anitschkov Lecture 2007. Atherosclerosis 202: 2-10.
4. Dean M, Hamon Y, Chimini G (2001) The human ATP-binding cassette (ABC) transporter superfamily. J Lipid Res 42: 1007-1017.
5. Oram JF, Lawn RM, Garvin MR, Wade DP (2000) ABCA1 is the cAMPinducible apolipoprotein receptor that mediates cholesterol secretion from macrophages. J Biol Chem 275: 34508-34511.
6. Brooks-Wilson A, Marcil M, Clee SM, Zhang LH, Roomp K, et al. (1999) Mutations in ABC1 in Tangier disease and familial high-density lipoprotein deficiency. Nat Genet 22: 336-345.
7. Rayner KJ, Suárez Y, Dávalos A, Parathath S, Fitzgerald ML, et al. (2010) MiR-33 contributes to the regulation of cholesterol homeostasis. Science 328: 1570-1573.
8. Najafi-Shoushtari SH, Kristo F, Li Y, Shioda T, Cohen DE, et al. (2010) MicroRNA-33 and the SREBP host genes cooperate to control cholesterol homeostasis. Science 328: 1566-1569.
9. Sacco J, Adeli K (2012) MicroRNAs: emerging roles in lipid and lipoprotein metabolism. Curr Opin Lipidol 23: 220-225.
10. Seppen J, Rijnberg M, Cooreman MP, Oude ER (2002) Lentiviral vectors for efficient transduction of isolated primary quiescent hepatocytes. J Hepatol 36: 459-465.
11. Hu YW, Ma X, Li XX, Liu XH, Xiao J, et al. (2009) Eicosapentaenoic acid reduces ABCA1 serine phosphorylation and impairs ABCA1-dependent cholesterol efflux through cyclic AMP/protein kinase A signaling pathway in THP-1 macrophage-derived foam cells. Atherosclerosis 204: e35-43.
12. Zhang Y, Da Silva JR, Reilly M, Billheimer JT, Rothblat GH, et al. (2005) Hepatic expression of scavenger receptor class B type I (SR-BI) is a positive regulator of macrophage reverse cholesterol transport in vivo. J Clin Invest 115: 2870-4.
13. Inoue S, Egashira K, Ni W, Kitamoto S, Usui M, et al. (2002) Anti-monocyte chemoattractant protein-1 gene therapy limits progression and destabilization of established atherosclerosis in apolipoprotein E-knockout mice. Circulation 106: 2700-6.
14. Recalde HR (1984) A simple method of obtaining monocytes in suspension. J Immunol Methods 69: 71-7.
15. Morrow DA, Cannon CP, Jesse RL, Newby LK, Ravkilde J, et al. (2007) National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines: Clinical characteristics and utilization of biochemical markers in acute coronary syndromes. Circulation 115: e356-375.
16. Tabas I (2002) Consequences of cellular cholesterol accumulation: basic concepts and physiological implications. Journal of Clinical Investigation 110: 905-911.
17. Østerud B, Bjorklid E (2003) Role of monocytes in atherogenesis. Physiological reviews 83: 1069-1112.
18. Libby P, Ridker P M, Maseri A (2002) Inflammation and atherosclerosis. Circulation 105: 1135-1143.
19. Breslow JL (1996) Mousemodels of atherosclerosis. Science 272: 685-688.
20. Virmani R, Kolodgie FD, Burke AP, Farb A, Schwartz SM (2000) Lessons from sudden coronary death: a comprehensive morphological classification scheme for atherosclerotic lesions. Arterioscler Thromb Vasc Biol 20: 1262-1275.
21. Guyton JR, Klemp KF (1996) Development of the lipid-rich core in human atherosclerosis. Arterioscler Thromb Vasc Biol 16: 4-11.
22. Redondo S, Mart?́nez-González J, Urraca C, Tejerina T (2011) merging therapeutic strategies to enhance HDL function. Lipids Health Dis 10: 175.
23. Barter P (2011) HDL-C: role as a risk modifier. Atheroscler Suppl 12: 267-270.
24. Watson AD, Leitinger N, Navab M, Faull KF, Hörkkö S, et al. (1997) Structural identification by mass spectrometry of oxidized phospholipids in minimally oxidized low density lipoprotein that induce monocyte/endothelial interactions and evidence for their presence in vivo. J Biol Chem 272: 13597-13607.
25. Farmer JA, Liao J (2011) Evolving concepts of the role of high-density lipoprotein in protection from atherosclerosis. Curr Atheroscler Rep 13: 107-114.
26. Oram JF (2003) HDL apolipoproteins and ABCA1 partners in the removal of excess cellular cholesterol. Arterioscler Thromb Vasc Biol 23: 720-727.
27. Oram JF, Lawn RM (2011) ABCA1: the gatekeeper for eliminating excess tissue cholesterol. J Lipid Res 42: 1173-1179.
28. Wang N, Tall AR (2003) Regulation and mechanisms of ATP-binding cassette transporter A1-mediated cellular cholesterol efflux. Arterioscler Thromb Vasc Biol 23: 1178-1184.
29. Wellington CL, Walker EK, Suarez A, Kwok A, Bissada N, et al. (2002) ABCA1 mRNA and protein distribution patterns predict multiple different roles and levels of regulation. Lab Invest 82: 273-283.
30. Iqbal J, Anwar K, Hussain MM (2003) Multiple, independently regulated pathways of cholesterol transport across the intestinal epithelial cells. J Biol Chem 278: 31610-31620.
31. Yin K, Deng X, Mo ZC, Zhao GJ, Jiang J, et al. (2011) Tristetraprolindependent post-transcriptional regulation of inflammatory cytokine mRNA expression by apolipoprotein A-I: role of ATP-binding membrane cassette transporter A1 and signal transducer and activator of transcription 3. J Biol Chem 286: 13834-13845.
32. Liu Y, Tang C (2012) Regulation of ABCA1 functions by signaling pathways. Biochim Biophys Acta 1821: 522-529.
33. Jahangiri A, de Beer MC, Noffsinger V, Tannock LR, Ramaiah C, et al. (2009) HDL remodeling during the acute phase response. Arterioscler Thromb Vasc Biol 29: 261-267.
34. McGillicuddy FC, de la Llera Moya M, Hinkle CC, Joshi MR, Chiquoine EH, et al. (2009) Inflammation impairs reverse cholesterol transport in vivo. Circulation 119: 1135-1145.
35. Tontonoz P, Nagy L, Alvarez JG, Thomazy VA, Evans RM (1998) PPARgamma promotes monocyte/macrophage differentiation and uptake of oxidized LDL. Cell 93: 241-252.
36. Nawroth PP, Stern DM (1987) Modulation of endothelial cell hemostatic properties by tumor necrosis factor. Onkologie 10: 254-258.
37. Dinarello CA (2000) The role of the interleukin-1-receptor antagonist in blocking inflammation mediated by interleukin-1. N Engl J Med 343: 732-734.
38. Lindmark E, Diderholm E, Wallentin L, Siegbahn A (2001) Relationship between interleukin 6 and mortality in patients with unstable coronary artery disease. JAMA 286: 2107-2113.
39. Bhayana V, Henderson AR (1995) Biochemical markers of myocardial damage. Clin Biochem 28: 1-29.
40. Kelley WE, Lockwood CM, Cervelli DR, Sterner J, Scott MG, et al. (2009) Cardiovascular disease testing on the Dimension Vista system: biomarkers of acute coronary syndromes. Clin Biochem 42: 1444-1451.
41. Dekker MS, Mosterd A, van 't Hof AW, Hoes AW (2010) Novel biochemical markers in suspected acute coronary syndrome: systematic review and critical appraisal. Heart 96: 1001-1010.
42. Beckman JA, Creager MA, Libby P (2002) Diabetes and atherosclerosis: epidemiology, pathophysiology, and management. JAMA 287: 2570-2581.
43. Devaux Y, Mueller M, Haaf P, Goretti E, Twerenbold R, et al. (2013) Diagnostic and prognostic value of circulating microRNAs in patients with acute chest pain. J Intern Med doi: 10.1111/joim.12183. [Epub ahead of print].
44. Sayed AS, Xia K, Yang TL, Peng J (2013) Circulating microRNAs: a potential role in diagnosis and prognosis of acute myocardial infarction. Dis Markers 35: 561-566.
45. Recchioni R, Marcheselli F, Olivieri F, Ricci S, Procopio AD, et al. (2013) Conventional and novel diagnostic biomarkers of acute myocardial infarction: a promising role for circulating microRNAs. Biomarkers 18: 547-558.
46. Huang S, Chen M, Li L, He M, Hu D, et al. (2014) Circulating microRNAs and the Occurrence of Acute Myocardial Infarction in Chinese Populations. Circ Cardiovasc Genet [Epub ahead of print]
47. Xiao J, Shen B, Li J, Lv D, Zhao Y, et al. (2014) Serum microRNA-499 and microRNA-208a as biomarkers of acute myocardial infarction. Int J Clin Exp Med 7: 136-141.
48. Long G, Wang F, Duan Q, Yang S, Chen F, et al. (2012) Circulating miR-30a, miR-195 and let-7b associated with acute myocardial infarction. PLoS One 7: e50926.